BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,719,847 | -16.7% | 807,888 | -17.1% | 0.03% | -12.8% |
| Q2 2023 | $6,863,740 | +0.3% | 974,963 | +18.8% | 0.04% | -15.2% |
| Q1 2023 | $6,843,145 | -22.4% | 820,521 | +6.8% | 0.05% | -37.8% |
| Q4 2022 | $8,817,478 | +35.8% | 768,073 | +49.1% | 0.07% | +7.2% |
| Q3 2022 | $6,492,000 | +58.4% | 515,228 | +33.0% | 0.07% | +81.6% |
| Q2 2022 | $4,098,000 | -24.0% | 387,327 | +16.8% | 0.04% | +18.8% |
| Q1 2022 | $5,394,000 | -14.0% | 331,713 | -26.7% | 0.03% | -3.0% |
| Q4 2021 | $6,269,000 | +112.8% | 452,637 | +120.8% | 0.03% | +65.0% |
| Q3 2021 | $2,946,000 | +19.4% | 204,998 | +31.3% | 0.02% | +25.0% |
| Q2 2021 | $2,468,000 | -7.9% | 156,107 | -40.8% | 0.02% | -11.1% |
| Q1 2021 | $2,681,000 | +220.3% | 263,584 | +134.6% | 0.02% | +125.0% |
| Q4 2020 | $837,000 | -53.7% | 112,351 | -78.7% | 0.01% | -63.6% |
| Q3 2020 | $1,808,000 | +70.4% | 526,302 | +136.4% | 0.02% | +46.7% |
| Q2 2020 | $1,061,000 | +3020.6% | 222,617 | +1194.3% | 0.02% | +1400.0% |
| Q1 2020 | $34,000 | -93.3% | 17,200 | -88.2% | 0.00% | -87.5% |
| Q4 2019 | $504,000 | -35.1% | 146,084 | -46.2% | 0.01% | -33.3% |
| Q3 2019 | $777,000 | -46.1% | 271,376 | -28.7% | 0.01% | -52.0% |
| Q2 2019 | $1,442,000 | +68.7% | 380,494 | +262.2% | 0.02% | +78.6% |
| Q1 2019 | $855,000 | – | 105,040 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |